Breaking News Instant updates and real-time market news.

WFC

Wells Fargo

$54.40

0.05 (0.09%)

06:01
12/02/19
12/02
06:01
12/02/19
06:01

Wells Fargo downgraded to Underperform from Market Perform at Raymond James

Raymond James analyst David Long downgraded Wells Fargo to Underperform from Market Perform.

  • 14

    Jan

WFC Wells Fargo
$54.40

0.05 (0.09%)

09/30/19
09/30/19
UPGRADE

Fly Intel: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. TSMC (TSM) upgraded to Conviction Buy from Buy at Goldman Sachs with analyst Bruce Lu saying after a re-examination of industry capacity builds and order revisions, he thinks he's underestimating the positive impacts on TSMC arising from trade uncertainty. 2. Wells Fargo (WFC) upgraded to Buy from Hold at Argus with analyst Stephen Biggar citing the company's appointment of Charlie Scharf as its new CEO. 3. Cigna (CI) upgraded to Outperform from Market Perform at BMO Capital with analyst Matthew Borsch claiming that the current 8-times his expected forward earnings valuation multiple is "attractive" as the stock represents a "better hedge" against political and health policy uncertainty. 4. Bed Bath & Beyond (BBBY) upgraded to Outperform from Neutral at Wedbush with analyst Seth Basham saying turning around declining retailers is a very difficult task, particularly amidst unfavorable secular trends and soft industry sales growth, but Bed Bath & Beyond has a "good chance of stabilization" in earnings over the next two years as its changes take hold. 5. Restaurant Brands (QSR) upgraded to Neutral from Underperform at Longbow with analyst Alton Stump saying after calls with U.S. Burger King franchisees, he believes same-store sales for Restaurant Brands' Burger King concept were up 4.5%-5.0% in Q3 ahead of his prior estimate of 2.0% growth and consensus at up 3.4%. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
10/16/19
BMOC
10/16/19
NO CHANGE
Target $57
BMOC
Market Perform
Wells Fargo price target lowered to $57 from $59 at BMO Capital
BMO Capital analyst James Fotheringham lowered his price target on Wells Fargo (WFC) to $57 and kept his Market Perform rating after its Q3 results. The analyst cites the bank's lower than expected net interest income along with a miss on fees and a higher than anticipated operating costs. Fotheringham contends that before the new Wells Fargo CEO arrives and administers a strategic review, there are better investment opportunities in large cap banks that include Citi (C), Bank of America (BAC), Capital One (COF) and Morgan Stanley (MS).
10/22/19
ODEN
10/22/19
DOWNGRADE
ODEN
Hold
Wells Fargo downgraded to Hold from Buy at Odeon Capital
Odeon Capital analyst Richard Bove downgraded Wells Fargo to Hold from Buy despite his view of the bank as "one of the most powerful companies in the United States" in spite of "all of its problems and all of its challenges." However, Wells' net interest margins will remain under pressure, sending its net interest income lower, while its costs are unlikely to decline any time soon and it faces more legal and regulatory issues, Bove tells investors.
11/15/19
ROTH
11/15/19
DOWNGRADE
Target $8
ROTH
Neutral
Mitek Systems downgraded on USAA litigation risk at Roth Capital
Roth Capital analyst Darren Aftahi downgraded Mitek Systems (MITK) to Neutral from Buy with a price target of $8, down from $12.50. The potential "trickle-down litigation risk" from USAA against Mitek's mobile deposit customer's acts is "too big of a risk/uncertainty to shares," Aftahi tells investors in a research note. He believes this could drag on for an extended period of time, causing distraction and additional legal costs. While Mitek does not believe it is the target of a lawsuit from USAA, the ruling in favor of USAA against Wells Fargo (WFC) could prove to be too big of a risk to justify buying Mitek shares currently, says Aftahi.

TODAY'S FREE FLY STORIES

SCHW

Charles Schwab

$51.08

1.48 (2.98%)

, AMTD

TD Ameritrade

$53.47

1.71 (3.30%)

07:46
12/13/19
12/13
07:46
12/13/19
07:46
Upgrade
Charles Schwab, TD Ameritrade, E-Trade rating change  »

Charles Schwab upgraded…

SCHW

Charles Schwab

$51.08

1.48 (2.98%)

AMTD

TD Ameritrade

$53.47

1.71 (3.30%)

ETFC

E-Trade

$46.01

1.08 (2.40%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Dec

  • 26

    Feb

07:45
12/13/19
12/13
07:45
12/13/19
07:45
General news
Treasury Market Outlook: it's rally time in equities »

Treasury Market Outlook:…

HIIQ

Health Insurance Innovations

$19.44

1.09 (5.94%)

, EHTH

eHealth

$93.74

0.89 (0.96%)

07:44
12/13/19
12/13
07:44
12/13/19
07:44
Recommendations
Health Insurance Innovations, eHealth analyst commentary  »

Health Insurance…

HIIQ

Health Insurance Innovations

$19.44

1.09 (5.94%)

EHTH

eHealth

$93.74

0.89 (0.96%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BMY

Bristol-Myers

$63.96

1.565 (2.51%)

07:43
12/13/19
12/13
07:43
12/13/19
07:43
Upgrade
Bristol-Myers rating change  »

Bristol-Myers upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FII

Federated Investors

$34.41

0.41 (1.21%)

07:42
12/13/19
12/13
07:42
12/13/19
07:42
Downgrade
Federated Investors rating change  »

JPMorgan downgrades…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SKX

Skechers

$41.65

0.89 (2.18%)

07:38
12/13/19
12/13
07:38
12/13/19
07:38
Upgrade
Skechers rating change  »

Skechers upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ORCL

Oracle

$56.47

0.16 (0.28%)

07:38
12/13/19
12/13
07:38
12/13/19
07:38
Recommendations
Oracle analyst commentary  »

Oracle price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OPI

Office Properties

$32.93

-1.02 (-3.00%)

07:37
12/13/19
12/13
07:37
12/13/19
07:37
Downgrade
Office Properties rating change  »

Morgan Stanley cuts…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

THTX

Theratechnologies

$3.05

-0.01 (-0.33%)

07:36
12/13/19
12/13
07:36
12/13/19
07:36
Hot Stocks
Theratechnologies reports results from in vitro, in vivo experiments on TH-1902 »

Theratechnologies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HWC

Hancock Whitney

$42.61

1.07 (2.58%)

07:35
12/13/19
12/13
07:35
12/13/19
07:35
Upgrade
Hancock Whitney rating change  »

Hancock Whitney upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GE

General Electric

$11.44

0.46 (4.19%)

, ATVI

Activision Blizzard

$58.60

2.12 (3.75%)

07:35
12/13/19
12/13
07:35
12/13/19
07:35
Options
Unusual call flow in option market yesterday »

Notable call activity was…

GE

General Electric

$11.44

0.46 (4.19%)

ATVI

Activision Blizzard

$58.60

2.12 (3.75%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

  • 29

    Jan

NPO

EnPro

$66.48

2.53 (3.96%)

07:34
12/13/19
12/13
07:34
12/13/19
07:34
Conference/Events
EnPro to host conference call »

Conference call to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BIIB

Biogen

$293.92

1.71 (0.59%)

07:33
12/13/19
12/13
07:33
12/13/19
07:33
Hot Stocks
Breaking Hot Stocks news story on Biogen »

Biogen to discontinue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BIIB

Biogen

$293.92

1.71 (0.59%)

07:32
12/13/19
12/13
07:32
12/13/19
07:32
Hot Stocks
Biogen: Primary endpoint not statistically significant in Phase 2 PASSPORT study »

Biogen announced topline…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ADBE

Adobe

$305.76

2.01 (0.66%)

07:32
12/13/19
12/13
07:32
12/13/19
07:32
Recommendations
Adobe analyst commentary  »

Adobe price target raised…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

CG

Carlyle Group

$29.83

-0.36 (-1.19%)

07:31
12/13/19
12/13
07:31
12/13/19
07:31
Hot Stocks
Funds advised by Apax Partners to acquire Coalfire from Carlyle Group, Chertoff »

Funds advised by Apax…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

ADBE

Adobe

$305.76

2.01 (0.66%)

07:30
12/13/19
12/13
07:30
12/13/19
07:30
Recommendations
Adobe analyst commentary  »

Adobe price target raised…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

SAFM

Sanderson Farms

$166.66

2.5 (1.52%)

07:30
12/13/19
12/13
07:30
12/13/19
07:30
Initiation
Sanderson Farms initiated  »

Sanderson Farms initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Dec

ORCL

Oracle

$56.47

0.16 (0.28%)

07:30
12/13/19
12/13
07:30
12/13/19
07:30
Recommendations
Oracle analyst commentary  »

Oracle shares to come…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AVGO

Broadcom

$327.39

7.53 (2.35%)

07:28
12/13/19
12/13
07:28
12/13/19
07:28
Recommendations
Broadcom analyst commentary  »

Broadcom price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NCLH

Norwegian Cruise Line

$56.12

0.72 (1.30%)

07:27
12/13/19
12/13
07:27
12/13/19
07:27
Recommendations
Norwegian Cruise Line analyst commentary  »

Norwegian Cruise Line…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ADBE

Adobe

$305.76

2.01 (0.66%)

07:26
12/13/19
12/13
07:26
12/13/19
07:26
Recommendations
Adobe analyst commentary  »

Adobe price target raised…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

ADBE

Adobe

$305.76

2.01 (0.66%)

07:25
12/13/19
12/13
07:25
12/13/19
07:25
Recommendations
Adobe analyst commentary  »

Adobe price target raised…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

DCP

DCP Midstream

$23.70

-0.56 (-2.31%)

07:25
12/13/19
12/13
07:25
12/13/19
07:25
Initiation
DCP Midstream initiated  »

DCP Midstream initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Jan

07:25
12/13/19
12/13
07:25
12/13/19
07:25
Conference/Events
UBS analyst manley to hold an analyst/industry conference call »

Analyst Manley discusses…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.